IDEATE: IPILIMUMAB DRUG EVALUATION

EUIPO EUIPO 2010 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark IDEATE: IPILIMUMAB DRUG EVALUATION was filed as Word mark on 08/06/2010 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/24/2010. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 9, 2024

Trademark form Word mark
File reference 009299281
Application date August 6, 2010
Publication date September 10, 2010
Entry date December 24, 2010
Expiration date August 6, 2030

Trademark owner

Route 206 & Province Line Road, Princeton,
08543 New Jersey
US

Trademark representatives

Waterways House, Grand Canal Quay D02 PD39 Dublin IE

goods and services

42 Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Trademark history

Date Document number Area Entry
January 12, 2024 Change Representative, Published
October 11, 2023 Transfer / Change of address, Published
January 24, 2022 Transfer / Change of address, Published
April 6, 2021 Change Representative, Published
January 19, 2021 Change Representative, Published
August 11, 2020 Extension, Trade mark renewed
December 2, 2019 Change Representative, Published

ID: 11009299281